We are live on
!
Find out more
CWAM
Columbia Wanger Asset Management Portfolio holdings
AUM
$6.69B
1-Year Est. Return
31.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.59%
1 Year Est. Return
+31.14%
3 Year Est. Return
+61.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.76B
AUM Growth
-$246M
(-3.5%)
Cap. Flow
-$554M
Cap. Flow
% of AUM
-8.19%
Top 10 Holdings %
Top 10 Hldgs %
14.12%
Holding
220
New
20
Increased
65
Reduced
117
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$46.1M |
| 2 |
Cognex
CGNX
|
+$41.7M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$41.5M |
| 4 |
Veeva Systems
VEEV
|
+$39.6M |
| 5 |
WUBA
58.com Inc
WUBA
|
+$36.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WAGE
WageWorks, Inc.
WAGE
|
+$44M |
| 2 |
Maximus
MMS
|
+$40.7M |
| 3 |
EGOV
NIC Inc
EGOV
|
+$40.1M |
| 4 |
Polaris
PII
|
+$39M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
+$38.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.29% |
| 2 | Industrials | 19.82% |
| 3 | Technology | 18.18% |
| 4 | Consumer Discretionary | 16.73% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Monro
MNRO
$398M
| $15.5M | 0.23% |
276,014
-295,350
| -52% | -$13.9M |
|
152
Celldex Therapeutics
CLDX
$3.28B
| $14.9M | 0.22% |
346,511
-221,930
| -39% | -$8.32M |
|
153
Vermilion Energy
VET
$1.66B
| $14.6M | 0.22% |
409,900
-625,393
| -60% | -$20.6M |
|
154
Lakeland Financial Corp
LKFN
$1.53B
| $14.3M | 0.21% |
293,223
-205,157
| -41% | -$9.27M |
|
|
ATRI
155
DELISTED
Atrion Corp
ATRI
| $13.6M | 0.2% |
20,241
-1,459
| -7% | -$936K |
|
|
MIME
156
DELISTED
Mimecast Limited
MIME
| $13.5M | 0.2% |
474,052
-38,502
| -8% | -$1.06M |
|
|
MB
157
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $13M | 0.19% |
502,881
+67,522
| +16% | +$1.67M |
|
158
Wabtec
WAB
$49.3B
| $13M | 0.19% |
171,126
-464,418
| -73% | -$35.7M |
|
|
AAMI
159
Acadian Asset Management
AAMI
$3.19B
| $12.7M | 0.19% |
849,080
-855,135
| -50% | -$12.2M |
|
|
AYX
160
DELISTED
Alteryx Inc
AYX
| $12.6M | 0.19% |
620,745
+113,666
| +22% | +$2.41M |
|
|
LTXB
161
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $12.6M | 0.19% |
316,620
-279,794
| -47% | -$10.5M |
|
|
162
Maximus
MMS
$3.1B
| $12.6M | 0.19% |
195,320
-664,030
| -77% | -$40.7M |
|
163
Bio-Techne
TECH
$11.3B
| $12.4M | 0.18% |
410,500
-295,444
| -42% | -$8.77M |
|
164
Liberty Global Class A
LBTYA
$3.6B
| $12.1M | 0.18% |
355,566
-133,120
| -27% | -$4.44M |
|
165
ICF International
ICFI
$1.72B
| $11.8M | 0.18% |
219,440
-50,260
| -19% | -$2.38M |
|
|
EXAS
166
DELISTED
Exact Sciences
EXAS
| $11.6M | 0.17% |
246,107
-19,989
| -8% | -$805K |
|
|
LOGM
167
DELISTED
LogMein, Inc.
LOGM
| $11.1M | 0.16% |
101,106
-8,216
| -8% | -$921K |
|
168
Ziff Davis
ZD
$1.98B
| $10.8M | 0.16% |
167,654
-122,868
| -42% | -$8.32M |
|
169
Hamilton Lane
HLNE
$5.57B
| $10.5M | 0.16% |
391,657
-31,811
| -8% | -$732K |
|
170
Anika Therapeutics
ANIK
$287M
| $10.2M | 0.15% |
175,710
-99,914
| -36% | -$5.22M |
|
171
HealthEquity
HQY
$8.75B
| $9.91M | 0.15% |
195,855
-15,912
| -8% | -$741K |
|
172
OceanFirst Financial
OCFC
$1.91B
| $9.89M | 0.15% |
+359,853
| New | +$9.38M |
|
173
Ambarella
AMBA
$3.81B
| $9.67M | 0.14% |
+197,284
| New | +$9.73M |
|
174
Healthcare Services Group
HCSG
$1.53B
| $9.67M | 0.14% |
179,144
-14,554
| -8% | -$748K |
|
175
TriCo Bancshares
TCBK
$1.83B
| $9.63M | 0.14% |
236,196
-19,188
| -8% | -$692K |
|
Similar funds
AP
RFS
CCCA
HTG
GP
IH
GL
TAM
Columbia Wanger Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Columbia Wanger Asset Management held 220 positions worth $6.76B, down 3.5% from $7.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Columbia Wanger Asset Management withdrew a net $554M in Q3 2017, closing 16 positions and reducing 117 holdings. Its most notable exit was NIC Inc, an estimated $40.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.
Against the trend, Columbia Wanger Asset Management opened a new position in Clovis Oncology, Inc. worth $47.9M.
- Columbia Wanger Asset Management's largest Q3 2017 buy was Clovis Oncology, Inc.: 581,660 shares worth $47.9M.
- Columbia Wanger Asset Management added most to Veeva Systems in Q3 2017, an estimated $39.6M increase.
- Columbia Wanger Asset Management's biggest Q3 2017 reduction was WageWorks, Inc., cutting an estimated $44M.
- Columbia Wanger Asset Management fully exited NIC Inc in Q3 2017, selling an estimated $40.1M.
- Columbia Wanger Asset Management's ten largest holdings make up 14% of its $6.76B portfolio in Q3 2017.
- Columbia Wanger Asset Management opened 20 new positions and closed 16 in Q3 2017.
- Columbia Wanger Asset Management's portfolio value fell 3.5% quarter-over-quarter to $6.76B.
Based on Columbia Wanger Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.